Antie D. Nevralgia and the diseases that resemble it. London, 1885. Borenstein.
Dejerine J. et al. Anatomie des centres nerveux (2 vol). Paris, Rueff, 1890-1901.
Клионер И.Л. Старческие и дегенеративные изменения в суставах и позвоночнике. М.: Медгиз, 1962, 151 с. [Klioner I.L. Senile and degenerative changes in the joints and spine. M.: Medgiz, 1962, 151 p.] (In Russ.)
Попелянский Я.Ю. Вертебральные синдромы поясничного остеохондроза. Казань: Изд-во Казан. университета, 1974;1:282. [Popeliansky I.Yu. Vertebral syndromes of lumbar osteochondrosis. Kazan: Kazan publishing house. University’s. 1974;1:282]. (In Russ.)
Скоромец A.A., Скоромец Т.А., Шумилина А.П. Остеохондроз дисков: новые взгляды на патогенез неврологических синдромов. Неврологический журнал. 1997;6:53-56. [Skoromets A.A., Skoromets T.A., Shumilina A.P. Low back pain disc: new views on the pathogenesis of neurological syndromes. Neurological journal. 1997;6:53-56.] (In Russ.)
Федин А.И. Дорсопатии (классификация и диагностика). Атмосфера. Нервные болезни. 2002;2:2-8. [Fedin A.I. Dorsopathy (classification and diagnosis). Atmosphere. Nervous disease. 2002;2:2-8.] (In Russ.)
Бехтерев В.М. Одеревенелость позвоночника с искривлением его как особая форма заболевания. Врач. 1892;36:899-903. [Bekhterev V.M. Stiffening of the spine with its curvature as a special form of the disease. Doctor. 1892;36:899-903.] (In Russ.)
Marie P. Sur la Spondylose rhizomelique. Rev. med. 1898;18:285.
Strumpell A. Bemerkungen uber die chroniche ankylosierende Entzendung der Wirbelsaule und der Hifigelenke. Disch. Z. Nervenheilk Leipzig. 1897;11:338.
Braun J., Golder W., Bollow M. et al. Imaging and scoring in ankylosing spondylitis. Clin. Exp. Rheumatol. 2002;20:178-184.
Coleman J.A. Cervical spine fraction in the ankylosing spondylitis patient. J. Am. Coll. Surg. 2005;201:318-320.
Бехтерев В.М. Об одеревенелости или сращении позвоночника с нервным симптомокомплексом. Русский врач. 1913;30:1053-1056. [Bekhterev V. M. On stiffening or fusion of the spine with a nervous symptom complex. Russian doctor. 1913;30:1053-1056.] (In Russ.)
McVeigh C.M., Cairns P.A. Diagnosis and management of ankylosing spondylitis. BMJ. 2006;16(333):581-585.
Rosenbaum J.T. Acute anterior uveitis and spondyloarthropathies. Rheum. Dis. Clin. North. Am. 1992;18:143-151.
Taurog J.D. The role of HLA-B27 in spondyloarthritis. J. Rheumatol. 2010;37:2606-2616.
Tiwana H., Natt R.S., Wilson C. et al. Correlation between the immune responses to collagens type I, III, IV and V and Klebsiella pneumoniae in patients with Crohn’s disease and ankylosing spondylitis. Rheumatology (Oxford). 2001;40:15-23.
Smith G.W., Blackwell C.C., Nuki G. Faecal flora in spondyloarthropathy. Br. J. Rheumatol. 1997;36:850-854.
Chatzikyriakidou A., Georgiou I., Voulgari P. et al. The role of tumor necrosis factor (TNF)- alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin. Exp. Rheumatol. 2009;27:645-648.
McVeigh C.M., Bell A.L., Cairns A.P. TNF inhibitors for ankylosing spondylitis in the real world. Rheumatol. Int. 2007;28:199-200.
Shamji M.F., Bafaquh M., Tsai E. The pathogenesis of ankylosing spondylitis. Neurosurg. Focus. 2008;24:E3.
Rigby A.S., Wood P.H. Diagnostic criteria for ankylosing spondylitis. Clin. Exp. Rheumatol. 1993;11:5-12.
Barr A., Keat A. Spondyloarthritides: evolving therapies. Arthritis Res. Ther. 2010;12:221-224. 23. Henderson C., Davis J.C. Drug insight: antitumor- necrosis-factor therapy for ankylosing spondylitis. Nat. Clin. Practice. Rheumatol. 2006;1-2:211-218.
Heldmann F., Braun J. et al. Update on biological therapy in the management of axial spondyloarthritis. Curr. Rheumatol. Rep. 2010;12:325-331.
Pohjolainen T., Jekunen A., Autio L, Vuorela H. Treatment of acute low back pain with the COX–2–selective anti–inflammatory drug nimesulide: results of a randomized, double– blind comparative trial versus ibuprofen. Spine. 2000;25:579-585.
Ilic K., Sefik M., Jankovic S. Efficacy and safety of two generic copies of nimesulide in patients with low back pain or know osteoarthritis. Reumatismo. 2009;61:27-33.
Suleyman H., Cadirci E., Albayrak A. Nimesulide is a selective COX-2 inhibitory, atypical nonsteroidal anti-inflammatory drug. Curr. Med. Chem. 2008;15:278-283.
Sharma S., Rastogi S., Gupta V. et al. Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection. Am. J. Ther. 1999;6:191-197.